Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC

Journal: Journal of Experimental Medicine

Published: 2021-04-05

DOI: 10.1084/jem.20200712

Affiliations: 4

Authors: 10

Go to article
Institutions Share
Georgia State University (GSU), United States of America (USA) 0.85
Xiamen Amoytop Biotech Co., Ltd., China 0.10
Harbin Medical University Cancer Hospital, China 0.05